Thomas Grunwald

Head of Group "Preclinical Studies"

Fraunhofer Institute for Cell Therapy and Immunology

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thomas Grunwald is the Head of Group "Preclinical Studies" at the Fraunhofer Institute for Cell Therapy and Immunology in Germany. His research focuses on immunotherapy, vaccine development, and viral disease mechanisms, as demonstrated by his recent articles on SARS-CoV-2 and respiratory syncytial virus. Dr. Grunwald is particularly interested in the efficacy of neutralizing monoclonal antibodies, vector tropism, and targeted immunization strategies.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

Leipzig University

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Grunwald

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity

TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma

Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system.

Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection.

Immunological Quantitation of the Glycation Site Lysine-414 in Serum Albumin in Human Plasma Samples by Indirect ELISA Using Highly Specific Monoclonal Antibodies.

Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.

Collaborators (5)

Anke Burger-Kentischer

Ulrike Koehl

Philip Gribbon

Daniel Ramsbeck

Ralf Hoffmann

Make your next move.